Neuroblastoma cells expressing the noradrenaline transporter are destroyed more selectively by 6-fluorodopamine than by 6-hydroxydopamine

Journal of Neurochemistry

Volumn 75, Issue 2, 2000, Pages 511-520

  Seitz, Gabriele ^b   Stegmann, Hartmut B ^c   Jäger, Heidrun H ^c   Schlude, Hans M ^c   Wolburg, Hartwig ^c   Roginsky, Vitaly A ^a   Niethammer, Dietrich ^c   Bruchelt, Gernot ^c  

^a RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c NONE

Author keywords

6 Fluorodopamine; 6 Hydroxydopamine; Electron paramagnetic resonance; Neuroblastoma; Noradrenaline transporter

Indexed keywords

6 FLUORODOPAMINE; NORADRENALIN; OXIDOPAMINE;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOOXIDATION; CATECHOLAMINE NERVE CELL; CYTOTOXICITY; ELECTRON SPIN RESONANCE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL SURVIVAL; CELL-FREE SYSTEM; DNA DAMAGE; DOPAMINE; DOPAMINE BETA-HYDROXYLASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINETICS; NEUROBLASTOMA; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; OXIDOPAMINE; OXYGEN CONSUMPTION; SYMPORTERS; TUMOR CELLS, CULTURED; TYROSINE 3-MONOOXYGENASE;

SIGANUS;

EID: 0033942804     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750511.x     Document Type: Article

References (41)

1. Angeletti P. U. and Levi-Montalcini R. (1970) Cytolytic effect of 6-hydroxydopamine on neuroblastoma cells. Cancer Res. 30, 2863-2869.
2. Beck J., Handgretinger R., Dopfer R., Klingebiel T., Niethammer D., and Gekeler V. (1995) Expression of mdr 1, mrp, topoisomerase II alpha/beta and cyclin A in primary or relapsed states of acute lymphoblastic leukemias. Br. J. Haematol. 89, 356-363.
3. Biedler J. L., Helson L., and Spengler B. A. (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33, 2643-2652.
4. Biedler J. L., Roffler-Tarlov S., Schachner M., and Freedman L. S. (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38, 3751-3757.
5. Breese G. R. and Taylor T. D. (1970) Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: evidence for selective degeneration of catecholamine neurons. J. Pharmacol. Exp. Ther. 174, 413-420.
6. Bruchelt G., Buck J., Girgert R., Treuner J., and Niethammer D. (1985) The role of reactive oxygen compounds derived from 6-hydroxydopamine for bone marrow purging from neuroblastoma cells. Biochem. Biophys. Res. Commun. 130, 168-174.
7. Buck J., Bruchelt G., Girgert R., Treuner J., and Niethammer D. (1985) Specific uptake of m-(125-I)iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Cancer Res. 45, 6366-6370.
8. Ciccarone V., Spengler B. A., Meyers M. B., Biedler J. L., and Ross R. A. (1989) Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 49, 219-225.
9. Cohen G. and Heikkila R. E. (1974) The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 249, 2447-2452.
10. Furlano D. C. and Kirk K. L. (1986) An improved synthesis of 4-fluoroveratrol. Efficient route to 6-fluoro-veratrolaldehyde and 6-fluoro-D,L-DOPA. J. Org. Chem. 51, 4073-4075.
11. Glowniak J. V., Kilty J. E., Amara S. A., Hoffman B. J., and Turner F. E. (1993) Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J. Nucl. Med. 34, 1140-1146.
12. Graham D. G., Tiffany S. M., Bell W. R. Jr., and Gutknecht W. F. (1978) Auto-oxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds toward C 1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14, 644-653.
13. 125I-labelled metaiodobenzylguanidine. Int. J. Cancer 45, 1164-1168.
14. Handgretinger R., Lang P., Schumm M., Taylor G., Neu S., Koscielnak E., Niethammer D., and Klingebiel T. (1998) Isolation and transplantation of autologous peripheral CD34(+) progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant. 21, 987-993.
15. Helson L., Helson C., Majeranowski A., Johnson G., and Traganos F. (1982) Plasma DOPA, DOPA sulfate and neuroblastoma, in International Congress Series 570: Pediatric Oncology (Raybaud C., Clement R., Lebreui G., and Bernard J. L., eds), pp. 110-114. Excerpta Medica, Amsterdam.
16. Ichitani Y., Okamura H., Nakahara D., Nagatsu I., and Ibata Y. (1994) Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra. Exp. Neurol. 130, 269-278.
17. Ivarone A., Servidei T., Riccardi R., Lasorella A., and Mastrangelo R. (1991) Specific uptake of 125-I-metaiodobenzylguanidine in human neuroblastoma cell lines is associated with the neuroblastic cell type. Prop. Clin. Biol. Res. 385, 447-454.
18. Kirk K. L., Cantacuzene D., Nimitkitpaisan Y., McCullogh D., Padgett W. L., Daly J. W., and Creveling C. R. (1979) Synthesis and biological properties of 2-, 5-, and 6-fluoronorepinephrines. J. Med. Chem. 22, 1493-1497.
19. Kushner B. H., Gulati S. C., Kwon J., O'Reilly R. J., Exelby P. R., and Cheung N. V. (1991) High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma. Cancer 68, 242-247.
20. Lode H. N., Bruchelt G., Seitz G., Gebhardt S., Gekeler V., Niethammer D., and Beck J. (1995) Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (mIBG) uptake and tyrosine hydroxylase gene expression. Ear. J. Cancer A 31, 586-590.
21. D2 immunocytochemistry. Eur. J. Cancer 33, 2024-2030.
22. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 65, 53-59.
23. Müller I., Jenner A., Bruchelt G., Niethammer D., and Halliwell B. (1997) Effect of concentration on the cytotoxic mechanism of doxorubicin - apoptosis and oxidative DNA damage. Biochem. Biophys. Res. Commun. 230, 254-257.
24. Pacholczyk T., Blakely R. D., and Amara S. G. (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350, 350-354.
25. Pileblad E., Magnusson T., and Fornstedt B. (1989) Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopaminedepleting action of 6-hydroxydopamine in rat striatum. J. Neurochem. 52, 978-980.
26. Purpura P., Westman L., Will P., Eidelman A., Kagan V. E., Osipov A. N., and Schor N. F. (1996) Adjunctive treatment of murine neuroblastoma with 6-hydroxydopamine and Tempol. Cancer Res. 56, 2336-2342.
27. Reynolds C. P., Reynolds D. A., Frenkel E. P., and Smith R. G. (1982) Selective toxicity of 6-hydroxydopamine for human neuroblastoma cell lines. Cancer Res. 42, 1331-1336.
28. Roginsky V. A., Barsukova T. K., Bruchelt G., and Stegmann H. B. (1997) The oxidation of catecholamines and 6-hydroxydopamine by molecular oxygen: effect of ascorbate. Z. Naturforsch. /C/ 52, 380-390.
29. Rotman A., Daly J. W., and Creveling C. R. (1976a) Oxygen-dependent reaction of 6-hydroxydopamine, 5,6-dihydroxytryptamine, and related compounds with proteins in vitro: a model for cytotoxicity. Mol. Pharmacol. 12, 887-899.
30. Rotman A., Daly J. W., Creveling C. R., and Breakefield X. O. (1976b) Uptake and binding of dopamine and 6-hydroxydopamine in murine neuroblastoma and fibroblast cells. Biochem. Pharmacol. 25, 383-388.
31. Sachs C. and Jonsson G. (1975) Mechanism of action of 6-hydroxydopamine. Biochem. Pharmacol. 24, 1-8.
32. Schlude H.-M., Köhle H., Seitz G., Bruchelt G., Roginsky V., and Stegmann H. B. (1997) Oxidative damage of neuroblastoma cells by 6-fluoro-dopamine as a source of OH-radicals, in Proceedings of the 2nd International Conference on Bioradicals (Kamada H. and Ohya H., eds), pp. 10-12. Yamagata Technopolis Foundation, Yamagata.
33. Schraufstätter I. U., Hinshaw D. B., Hyslop P. A., Spragg R. G., and Cochrane C. G. (1986) Oxidant injury of cells. J. Clin. Invest. 77, 1312-1320.
34. Seitz G., Gebhardt S., Beck J. F., Böhm W., Lode H. N., Niethammer D., and Bruchelt G. (1998) Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH. Neurosci. Lett. 244, 33-36.
35. Shimada S., Kitayama S., Lin Ch., Patel A., Nanthakumar E., Gregor P., Kuhar M., and Uhl G. (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576-578.
36. Singh N. P., McCoy M. T., Tice R. R., and Schneider E. L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175, 184-191.
37. Smets L. A., Loesberg C., Janssen M., Metwally E. A., and Huiskamp R. (1989) Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells. Cancer Res. 49, 2941-2944.
38. Thurman R. G., Ley H. G., and Scholz R. (1972) Hepatic microsomal ethanol oxidations, hydrogen peroxide formation and the role of catalase. Eur. J. Biochem. 25, 420-430.
39. Uretsky N. J. and Iversen L. L. (1970) Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain. J. Neurochem. 17, 269-278.
40. Usdin T. B., Mezey E., Chen C., Brownstein M. J., and Hoffman B. J. (1991) Cloning of the cocaine-sensitive bovine dopamine transporter. Proc. Natl. Acad. Sci. USA 88, 11168-11171.
41. Zaizen Y., Nakagawara A., and Ikeda K. (1986) Patterns of destruction of mouse neuroblastoma cells by extracellular hydrogen peroxide formed by 6-hydroxydoparnine and ascorbate. J. Cancer Res. Clin. Oncol. 111, 93-97.